Enliven Therapeutics, Inc. · NASDAQ:ELVN
FMR LLC reported a 15.00% stake in Enliven Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 6, 2026
FMR LLC reported a 15.00% stake in Enliven Therapeutics, Inc., 10,713,540 shares, as a passive investor on Jun 30, 2026. Filed Aug 6, 2026 (Schedule 13G/A).
- Stake
- 15.00%
- Shares
- 10,713,540
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 15.00% | 10,713,540 |
| Abigail P. Johnson | 15.00% | 10,713,540 |
Source
Related
- Enliven Therapeutics, Inc.
- FMR LLC
- Enliven Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · Nov 5, 2025
- Form 4 · Garland J. Scott · Oct 5, 2026
- Form 4 · Hohl Benjamin · Sep 21, 2026
- Form 4 · Collins Helen Louise · Sep 21, 2026
- Form 4 · Hohl Benjamin · Aug 19, 2026
- Form 4 · Collins Helen Louise · Aug 19, 2026